Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Macon, GA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Roswell, GA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Bloomfield Hills, MI
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Morehead City, NC
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Morehead City, NC
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Austin, TX
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Parkville,
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Parkville,
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Concord, CA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Concord, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Escondido, CA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Escondido, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Ventura, CA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Ventura, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Aurora, CO
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Orlando, FL
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Atlanta, GA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
New Orleans, LA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Rockville, MD
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Boston, MA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Omaha, NE
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Las Vegas, NV
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Albany, NY
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Asheville, NC
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Chapel Hill, NC
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Greenville, NC
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Bend, OR
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Bend, OR
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
San Antonio, TX
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Salt Lake City, UT
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
Seattle, WA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated:  12/20/2017
Lexicon Investigational Site
mi
from
San Marcos, CA
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
Status: Enrolling
Updated: 12/20/2017
Lexicon Investigational Site
mi
from
San Marcos, CA
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
University of California at San Francisco
mi
from
San Francisco, CA
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Stanford University
mi
from
Stanford, CA
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Barbara Davis Center
mi
from
Aurora, CO
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Barbara Davis Center
mi
from
Aurora, CO
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Yale University
mi
from
New Haven, CT
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
University of Florida
mi
from
Gainesville, FL
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
University of Miami
mi
from
Miami, FL
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
University of South Florida Diabetes Center
mi
from
Tampa, FL
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
University of South Florida Diabetes Center
mi
from
Tampa, FL
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Indiana University-Riley Hospital for Children
mi
from
Indianapolis, IN
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Indiana University-Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Univ of Minnesota
mi
from
Minneapolis, MN
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Columbia University Naomi Berrie Diabetes Center
mi
from
New York, NY
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Columbia University Naomi Berrie Diabetes Center
mi
from
New York, NY
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Vanderbilt Eskind Diabetes Clinic
mi
from
Nashville, TN
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Vanderbilt Eskind Diabetes Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2017
Benaroya Research Institute
mi
from
Seattle, WA
ATG-GCSF in New Onset Type 1 Diabetes
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2017
Benaroya Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
Uncoupling Protein Polymorphisms and Cardiometabolic Responses to Beta-Blockers
Status: Enrolling
Updated:  12/22/2017
University of Maryland
mi
from
Baltimore, MD
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
Uncoupling Protein Polymorphisms and Cardiometabolic Responses to Beta-Blockers
Status: Enrolling
Updated: 12/22/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
Anaheim, CA
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
North Hollywood, CA
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
Duncansville, PA
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
Knoxville, TN
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
El Cajon, CA
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
San Antonio, TX
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/27/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/27/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
Status: Enrolling
Updated:  12/27/2017
Columbia University Medical Center
mi
from
New York, NY
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
Status: Enrolling
Updated: 12/27/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers
KCI VAC Protocol VAC2001-08, "A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in the Treatment and Blinded Evaluation of Diabetic Foot Ulcers"
Status: Enrolling
Updated:  12/29/2017
Maricopa Medical Center
mi
from
Phoenix, AZ
Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers
KCI VAC Protocol VAC2001-08, "A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in the Treatment and Blinded Evaluation of Diabetic Foot Ulcers"
Status: Enrolling
Updated: 12/29/2017
Maricopa Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials